BIOS Key Statistics, Chart & Performance
The current stock price of BIOS is 10.795 USD. In the past month the price increased by 0.05%. In the past year, price increased by 7.41%.
BIOS Latest News, Press Relases and Analysis
About BIOS
Company Profile
BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2021-12-03. The firm is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm intends to focus its search on companies in the life sciences industry. The firm has not commenced any operations nor generated any revenue.
Company Info
BIOPLUS ACQUISITION CORP-A
260 Madison Avenue, Suite 800
New York City NEW YORK 60015 US
CEO: Daniel E. Greenleaf
Employees: 2
Phone: 12122874092.0
BIOPLUS ACQUISITION CORP-A / BIOS FAQ
What does BIOPLUS ACQUISITION CORP-A do?
BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2021-12-03. The firm is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm intends to focus its search on companies in the life sciences industry. The firm has not commenced any operations nor generated any revenue.
Can you provide the latest stock price for BIOPLUS ACQUISITION CORP-A?
The current stock price of BIOS is 10.795 USD. The price decreased by -0.05% in the last trading session.
What is the dividend status of BIOPLUS ACQUISITION CORP-A?
BIOS does not pay a dividend.
What is the ChartMill rating of BIOPLUS ACQUISITION CORP-A stock?
BIOS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is BIOS stock listed?
BIOS stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for BIOS stock?
The PE ratio for BIOPLUS ACQUISITION CORP-A (BIOS) is 53.97. This is based on the reported non-GAAP earnings per share of 0.2 and the current share price of 10.795 USD.
BIOS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to BIOS. When comparing the yearly performance of all stocks, BIOS turns out to be only a medium performer in the overall market: it outperformed 69.38% of all stocks.
BIOS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BIOS. BIOS may be in some trouble as it scores bad on both profitability and health.
BIOS Financial Highlights
Over the last trailing twelve months BIOS reported a non-GAAP Earnings per Share(EPS) of 0.2. The EPS increased by 1103.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 4.18% | ||
| ROE | 4.75% | ||
| Debt/Equity | 0.04 |